Role of fibroblast growth factor-23 in renal disease activity and bone density involvement in patients with lupus nephritis

Figure 1 Mean fibroblast growth factor-23 in patients with inactive and active lupus nephritis and in the studied patient groups based on bone mineral density. A: Patients with inactive and active lupus nephritis; B: Studied patient groups based on bone mineral density. BMD: Bone mineral density; LN: Lupus nephritis.

Figure 2 Receiver operating characteristics curve for predictive value of fibroblast growth factor-23 in the prediction of low bone mineral density in patients with lupus nephritis and active lupus nephritis. A: The prediction of low bone mineral density in patients with lupus nephritis; B: The prediction of active lupus nephritis.